Vaccine: X
Scope & Guideline
Elevating public health through innovative vaccine solutions.
Introduction
Aims and Scopes
- Vaccine Development and Technology:
Research related to the formulation, manufacturing processes, and technological advancements in vaccine production, including novel delivery systems and adjuvants. - Efficacy and Safety Studies:
Evaluations of vaccine effectiveness, safety profiles, and post-marketing surveillance to monitor adverse events and long-term immune responses. - Public Health and Epidemiology:
Studies assessing vaccination coverage, public health outcomes, and the epidemiological impact of vaccination programs in various demographics. - Vaccine Hesitancy and Acceptance:
Research focusing on factors influencing vaccine uptake, including sociocultural, psychological, and behavioral aspects of vaccine hesitancy. - Global Health and Equity:
Investigations into disparities in vaccine access and coverage in low- and middle-income countries, addressing the challenges and strategies to improve vaccination rates.
Trending and Emerging
- COVID-19 Vaccine Research:
A surge in studies related to COVID-19 vaccines, including their effectiveness, safety, and the impact of variants, has become a dominant theme in recent publications. - Vaccine Equity and Access:
Increasing emphasis on global vaccine equity, particularly in the context of low- and middle-income countries, highlighting barriers to access and strategies for improvement. - Innovative Vaccine Delivery Systems:
Research on advanced vaccine delivery techniques, such as intranasal and microneedle vaccinations, is gaining attention for their potential to improve immunization coverage. - Vaccine Hesitancy Interventions:
Growing interest in understanding and addressing vaccine hesitancy through targeted interventions and communication strategies, particularly in diverse populations. - Immunological Studies Post-Vaccination:
Emerging studies that focus on understanding the immune responses following vaccination, including long-term immunity and booster dose efficacy, are increasingly prevalent.
Declining or Waning
- Traditional Vaccination Methods:
Studies on conventional vaccination methods are becoming less prominent as research shifts toward innovative delivery systems and technologies. - Vaccination for Diseases with Declining Incidence:
Research on vaccination for diseases that have significantly declined in incidence due to successful public health interventions is waning, as focus moves towards emerging infectious diseases. - Single-Disease Focus Studies:
There is a decreasing trend in research that solely focuses on vaccines for single diseases, as there is a growing interest in multi-disease vaccination strategies.
Similar Journals
Infektsiya i Immunitet
Connecting scholars to vital discoveries in health.Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
Pioneering Research in Tropical Health ChallengesREVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO is a prestigious open-access journal that has been publishing significant research in the field of tropical medicine since its inception in 1961. Produced by the Instituto de Medicina Tropical de São Paulo, the journal boasts a commendable Q3 ranking in both the categories of Infectious Diseases and Medicine (miscellaneous), as per the latest 2023 metrics. With an ISSN of 0036-4665 and E-ISSN of 1678-9946, it serves as a prominent platform for scholars and professionals to disseminate their findings and insights on pressing health issues prevalent in tropical regions, particularly those relevant to Brazil and beyond. This journal is essential for researchers and practitioners who seek to advance their understanding and apply innovative solutions in tropical medicine, thus addressing the distinct challenges posed by infectious diseases in diverse populations. The journal is accessible through various open access platforms, ensuring that critical research is available to a global audience, fostering knowledge sharing and collaboration.
Influenza and Other Respiratory Viruses
Exploring the frontiers of viral epidemiology.Influenza and Other Respiratory Viruses, published by WILEY, serves as a prominent peer-reviewed platform for the dissemination of research contributing to the understanding and management of respiratory viral infections. With an impressive impact factor and established as an Open Access journal since 2014, it ensures maximum visibility and accessibility of pivotal research findings in the realm of Epidemiology, Infectious Diseases, Public Health, and Pulmonary and Respiratory Medicine. Registered under the ISSN 1750-2640 and E-ISSN 1750-2659, the journal boasts Q1 rankings in four critical categories as of 2023, underscoring its significance within the scientific community. Researchers, professionals, and students can benefit from the convergence of knowledge that this journal facilitates from 2007 to 2024, fostering advancements in understanding viral pathogens and innovative treatment strategies that are increasingly vital to public health efforts globally.
Osong Public Health and Research Perspectives
Disseminating vital research to tackle health challenges worldwide.Osong Public Health and Research Perspectives is an esteemed open-access journal dedicated to advancing knowledge in the fields of Public Health and Infectious Diseases. Published by the Korea Disease Control & Prevention Agency, this journal serves as a vital resource for researchers, professionals, and students alike, addressing significant health challenges and disseminating research findings that contribute to public health advancements worldwide. Recognized for its impact, the journal boasts a Q2 ranking in both Infectious Diseases and Public Health, Environmental and Occupational Health categories, as well as a prestigious 94th percentile in Scopus rankings, underscoring its influence and quality. Since its inception in 2010, Osong Public Health and Research Perspectives has provided open access to critical research, ensuring that vital information is readily available to enhance public health initiatives and policy-making. With a commitment to upholding high academic standards, this journal continues to be a cornerstone for collaborative research and discourse within the global health community.
Journal of Pediatric Infection
Fostering collaboration in global pediatric research.Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.
Open Forum Infectious Diseases
Fostering collaboration in the fight against infectious diseases.Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.
Infectious Diseases and Therapy
Transforming knowledge into therapeutic practices.Infectious Diseases and Therapy is a premier scholarly journal published by Springer London Ltd, dedicated to advancing the understanding of infectious diseases through rigorous research and evidence-based therapy. With an esteemed Q1 ranking in both the Infectious Diseases and Microbiology (medical) categories, this journal is a vital resource for researchers, healthcare professionals, and students aiming to stay at the forefront of developments within the field. Launched in 2012, it has embraced an Open Access model, ensuring that groundbreaking studies and critical reviews are accessible to a global audience. Operating from its office in London, the journal encourages the dissemination of innovative therapies and diagnostic methods, fostering collaboration and knowledge sharing among the scientific community. In a landscape where infectious diseases pose significant health challenges, Infectious Diseases and Therapy stands as an essential platform for impactful research that can lead to improved healthcare outcomes worldwide.
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE
Exploring the Frontiers of Microbial and Immune ResearchEPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE is a prominent scholarly journal published by CESKA LEKARSKA SPOLECNOST J EV PURKYNE in the Czech Republic. With an ISSN of 1210-7913, this journal has been at the forefront of research since its inception in 1994, showcasing a rich repository of studies bridging the domains of epidemiology, microbiology, immunology, and infectious diseases, and reflecting advancements over three decades. Although it currently falls within the Q4 category in multiple fields including Epidemiology and Microbiology, the journal serves an essential role in disseminating knowledge and fostering discussions around public health challenges. The contributions made through its pages are vital for researchers, healthcare professionals, and students aiming to enhance their understanding of complex biomedical issues. While it does not offer open access, the journal remains a critical resource in its niches, inviting readers to engage with the latest findings and methodologies reshaping the landscape of health science.
Tropical Diseases Travel Medicine and Vaccines
Connecting research and practice for a healthier tomorrow.Tropical Diseases Travel Medicine and Vaccines, published by SPRINGERNATURE, stands at the forefront of research in the fields of infectious diseases and public health, with an impressive impact factor that signifies its relevance and influence. Since its inception in 2015, this peer-reviewed journal has maintained an open access policy, ensuring that cutting-edge research on tropical diseases and travel medicine is readily available to researchers, professionals, and students worldwide. The journal currently ranks in the Q2 Quartile for both Infectious Diseases and Public Health, Environmental and Occupational Health, reflecting its substantial contribution to these critical areas of study. With a strong Scopus rank of #176 in Public Health and #138 in Infectious Diseases, it serves as a vital platform for innovative studies that advance understanding and response strategies related to tropical diseases. For its vast audience, Tropical Diseases Travel Medicine and Vaccines not only acts as a bridge connecting researchers with practical applications but also nurtures academic discourse essential for future advancements in global health.
Vaccine
Advancing global health through innovative vaccine research.Vaccine is a premier academic journal published by Elsevier Science Ltd, dedicated to the field of vaccination and immunization research. With an impact factor and H-index that underscore its significance in the scientific community, this journal has consistently ranked in the Q1 category within various fields, including Immunology and Microbiology, Infectious Diseases, and Public Health. Since its inception in 1983, it has served as a vital resource for researchers, healthcare professionals, and students, providing rigorous peer-reviewed articles that explore important breakthroughs and innovations in vaccine development and deployment. Although it does not operate under an Open Access model, the journal maintains high visibility within academic circles, thanks to its strategic collaborations and widely respected editorial board. By bridging the gaps between laboratory discoveries and clinical applications, Vaccine plays a crucial role in advancing global health initiatives and addressing urgent public health challenges.